In the young adult psoriasis population, substantial quality of life (QOL) impairments were found, according to a recent study. Furthermore, female patients, patients with high body mass index (BMI), or long disease duration in particular tended to experience more difficulties. An explorative, cross-sectional study was performed in psoriasis patients aged 18–30 years. Individuals completed a set of questionnaires regarding their health status, achievement of developmental milestones, and work productivity. Participants consisted of 75 patients (22 males, 53 females; median age [IQR], 21.0 [8.0]). Researchers found:
- Median Psoriasis Area Severity Index (PASI) and Body Surface Area (BSA), respectively, were 4.4 [4.9] and 4.5 [8.4].
- Young adults experienced feelings of embarrassment, impairments in physical health and work productivity, and difficulties in social development.
- Patients with more severe psoriasis, longer disease duration, and higher BMI tended to be more affected, as well as female patients and patients closer to their 30s.
Bronckers IMGJ, van Geel MJ, van de Kerkhof PCM, de Jong EMGJ, Seyger MMB. A cross-sectional study in young adults with psoriasis: Potential determining factors in quality of life, life course and work productivity. [Published online ahead of print September 7, 2018]. J Dermatolog Treat. doi:10.1080/09546634.2018.1506077.
This Week's Must Reads
Cutaneous Pleomorphic Sarcoma Prognosis Examined, J Am Acad Dermatol; ePub 2018 Nov 8; Ibanez, et al
Early Desmoplastic Melanoma Treatment Comparison, Melanoma Res; ePub 2018 Oct 31; Abbott, et al
Gestational Weight Gain, AD in Offspring Linked, J Allergy Clin Immunol; ePub 2018 Nov 8; Drucker, et al
Racial/Ethnic Differences Examined in Persistent AD, J Invest Dermatol; ePub 2018 Nov 8; Kim, et al
As Temperatures Increase, So Do AD Office Visits , Int J Dermatol, ePub 2018 Nov 11; Fleischer
Must Reads in Psoriasis
Psoriasis Associated with Sexual Dysfunction, JAMA Dermatol; ePub 2018 Oct 10; Molina-Leyva, et al
Association Between Psoriasis and Suicide Examined, Dermatolog Ther; ePub 2018 Oct 12; Liang, et al
FDA Approves Hyrimoz for Plaque Psoriasis, Sandoz news release; 2018 Oct 31
Psoriasis Treatment Receives Tentative FDA Approval, Bausch Heath news release; 2018 Oct 8
Young Adults with Psoriasis Have Impaired QOL, J Dermatolog Treat; ePub 2018 Sep 7; Bronckers, et al